Lv1
20 积分 2024-11-11 加入
Global, regional, and national burdens of atopic dermatitis from 1990 to 2021: A trend analysis from the Global Burden of Disease Study 2021
2个月前
已完结
Efficacy and safety of retatrutide, a GIP, GLP-1, and glucagon receptor agonist, in people with type 2 diabetes and inadequate glycaemic control with diet and exercise (TRANSCEND-T2D-1): a double-blind, randomised, phase 3 trial
3个月前
已完结
Guideline for the diagnosis and treatment of psoriasis in China （2018 complete edition）
3个月前
已完结
A Phase 3 Trial of Brepocitinib in Dermatomyositis
3个月前
已完结
Efficacy and safety of retatrutide, a GIP, GLP-1, and glucagon receptor agonist, in people with type 2 diabetes and inadequate glycaemic control with diet and exercise (TRANSCEND-T2D-1): a double-blind, randomised, phase 3 trial
3个月前
已完结
Abrocitinib versus dupilumab: Impact on skin barrier function and proteomics in atopic dermatitis
4个月前
已完结
Association between coffee and caffeine intake and risk of COPD: Findings based on NHANES 2007-2012
1年前
已完结
皖公网安备34019202002308
